Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.

Sakai Y, Dobson C, Diksic M, Aubé M, Hamel E.

Neurology. 2008 Feb 5;70(6):431-9. doi: 10.1212/01.wnl.0000299095.65331.6f.

PMID:
18250288
2.

α-[11C] methyl-L tryptophan-PET as a surrogate for interictal cerebral serotonin synthesis in migraine without aura.

Sakai Y, Nishikawa M, Diksic M, Aubé M.

Cephalalgia. 2014 Mar;34(3):165-73. doi: 10.1177/0333102413506126. Epub 2013 Sep 20.

PMID:
24057438
3.
4.

Revisiting the efficacy of sumatriptan therapy during the aura phase of migraine.

Aurora SK, Barrodale PM, McDonald SA, Jakubowski M, Burstein R.

Headache. 2009 Jul;49(7):1001-4. doi: 10.1111/j.1526-4610.2009.01429.x. Epub 2009 Apr 28.

5.

Sumatriptan and cerebral blood flow velocity changes during migraine attacks.

Totaro R, De Matteis G, Marini C, Baldassarre M, Carolei A.

Headache. 1997 Nov-Dec;37(10):635-9.

PMID:
9439084
6.
7.

[Suppressing effect of the serotonin 5HT1B/D receptor agonist rizatriptan on calcitonin gene-related peptide (CGRP) concentration in migraine attacks].

Stepień A, Jagustyn P, Trafny EA, Widerkiewicz K.

Neurol Neurochir Pol. 2003 Sep-Oct;37(5):1013-23. Polish.

PMID:
15174248
8.

Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial.

Di Monda V, Nicolodi M, Aloisio A, Del Bianco P, Fonzari M, Grazioli I, Uslenghi C, Vecchiet L, Sicuteri F.

Headache. 2003 Sep;43(8):835-44.

PMID:
12940804
9.
10.

The biology of serotonin receptors: focus on migraine pathophysiology and treatment.

Hamel E.

Can J Neurol Sci. 1999 Nov;26 Suppl 3:S2-6. Review.

PMID:
10563226
11.

Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.

Göbel H, Winter P, Boswell D, Crisp A, Becker W, Hauge T, Mihout B, Niewold J, Tørring J.

Clin Ther. 2000 Aug;22(8):981-9.

PMID:
10972634
12.
13.

Brain stem activation in spontaneous human migraine attacks.

Weiller C, May A, Limmroth V, Jüptner M, Kaube H, Schayck RV, Coenen HH, Diener HC.

Nat Med. 1995 Jul;1(7):658-60.

PMID:
7585147
15.

Sumatriptan and naproxen sodium for the acute treatment of migraine.

Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ.

Headache. 2005 Sep;45(8):983-91.

PMID:
16109111
16.

Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.

Wang X, Fang Y, Liang J, Yin Z, Miao J, Luo N.

Headache. 2010 Apr;50(4):579-87. doi: 10.1111/j.1526-4610.2010.01632.x. Epub 2010 Mar 5.

PMID:
20236348
17.

Alpha[11C] methyl-L-typtophan positron emission tomography in patients with alternating hemiplegia of childhood.

Pfund Z, Chugani DC, Muzik O, Juhász C, Behen ME, Lee J, Chakraborty P, Mangner T, Chugani HT.

J Child Neurol. 2002 Apr;17(4):253-60.

PMID:
12088079
18.

Upregulated expression of peripheral serotonergic receptors in migraine and cluster headache by sumatriptan.

Martelletti P, Stirparo G, Rinaldi C, Giacovazzo M.

Int J Clin Pharmacol Res. 1994;14(5-6):165-75.

PMID:
7672873
20.

Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.

Seeburger JL, Taylor FR, Friedman D, Newman L, Ge Y, Zhang Y, Hustad CM, Lasorda J, Fan X, Hewitt D, Ho T, Connor KM.

Cephalalgia. 2011 May;31(7):786-96. doi: 10.1177/0333102410390399. Epub 2010 Nov 15.

PMID:
21078681

Supplemental Content

Support Center